Roche logo
Roche
RHHBY | OTC
Chart Builder DCF Calculator
$60.98
+$0.68 (+1.13%)
At close: Nov 16, 2026, 3:59 PM ET
$60.95
-$0.03 (-0.05%)
After-hours: Nov 16, 2026, 4:00 PM ET

Roche Company Profile

Company profile explained

Company Profile

Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company boasts an extensive international presence, with key operations located in countries such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium. Its pharmaceutical division is dedicated to creating and supplying a diverse array of therapeutic remedies. These target a broad spectrum of medical fields, including oncology, neuroscience, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments. The comprehensive product line further extends to treatments for specific conditions like infectious diseases, anemia, various dermatological issues, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation-related needs. Within its diagnostics segment, Roche develops and markets a wide variety of laboratory-based tests designed to identify and monitor numerous illnesses. These include, but are not limited to, cancer, diabetes, Covid-19, hepatitis, and human papillomavirus. Additionally, the company is a provider of essential diagnostic instruments and reagents. Established in 1896, Roche Holding AG maintains its corporate headquarters in Basel, Switzerland.

Key Executives

Name Position
Thomas Schinecker Group Chief Executive Officer
Alan Hippe Chief Financial Officer
Maria Cristina A. Wilbur Chief People Officer
Boris L. Zaitra Head of Corporate Business Development
Bruno Eschli Head of Investor Relations
Claudia Bockstiegel General Counsel
Nicolas Dunant Head of Group Media Relations
Nina Schwab-Hautzinger Head of Group Communications
Severin Schwan Executive Chairman
Wafaa Mamilli Chief Digital & Technology Officer
Roche
Roche logo
Country Switzerland
IPO Date Aug 20, 2003
Industry Drug Manufacturers - General
Sector Healthcare
Employees 103,249
CEO Thomas Schinecker

Contact Details

Grenzacherstrasse 124 Basel, BS 4070 Switzerland

Stock Details

Ticker Symbol RHHBY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 771195104
ISIN Number US7711951043
SIC Code n/a

Recent News

More News ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.